Literature DB >> 25014052

Epilepsy and phenylketonuria: a case description and EEG-fMRI findings.

Melania Guida, Ilaria Pesaresi, Serena Fabbri, Ferdinando Sartucci, Mirco Cosottini, Filippo Sean Giorgi.   

Abstract

Phenylketonuria (PKU) is characterized by phenylalanine accumulation due to phenylalanine hydroxylase deficiency. Up to 50% of PKU patients experience seizures. We evaluated an adult PKU patient who suffered from absences and primarily generalized tonicclonic seizures, associated with generalized spikeand-wave discharges (GSWs) on EEG. An analysis of blood oxygenation level-dependent (BOLD) signal changes during interictal epileptiform discharges showed early activation of the left perirolandic cortex followed by a BOLD signal decrease within cortical regions belonging to the default mode network and left frontoparietal cortex. Moreover, deactivation of the head of the right caudate nucleus and the left thalamus was observed. The fMRI pattern observed in our patient during GSWs is similar but not identical to that observed in idiopathic generalized epilepsy, suggesting different neurophysiological mechanisms. This is the first description of BOLD-fMRI patterns in a PKU patient with epilepsy. Similar studies in more patients might help to uncover the pathophysiology of seizures in this disease.

Entities:  

Mesh:

Year:  2014        PMID: 25014052      PMCID: PMC4172251     

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  22 in total

1.  EEG-fMRI of idiopathic and secondarily generalized epilepsies.

Authors:  Khalid Hamandi; Afraim Salek-Haddadi; Helmut Laufs; Adam Liston; Karl Friston; David R Fish; John S Duncan; Louis Lemieux
Journal:  Neuroimage       Date:  2006-04-19       Impact factor: 6.556

2.  Absence seizures: individual patterns revealed by EEG-fMRI.

Authors:  Friederike Moeller; Pierre LeVan; Hiltrud Muhle; Ulrich Stephani; Francois Dubeau; Michael Siniatchkin; Jean Gotman
Journal:  Epilepsia       Date:  2010-08-17       Impact factor: 5.864

3.  EEG-fMRI study of the ictal and interictal epileptic activity in patients with eyelid myoclonia with absences.

Authors:  Yonghong Liu; Tianhua Yang; Wei Liao; Xuhong Yang; Iing Liu; Bo Yan; Huafu Chen; Qiyong Gong; Hermann Stefan; Dong Zhou
Journal:  Epilepsia       Date:  2008-07-24       Impact factor: 5.864

4.  Reproducibility of BOLD localization of interictal activity in patients with focal epilepsy: intrasession and intersession comparisons.

Authors:  Ilaria Pesaresi; Mirco Cosottini; Gina Belmonte; Patrizia Maritato; Mario Mascalchi; Michele Puglioli; Ferdinando Sartucci; Carlo Bartolozzi; Luigi Murri
Journal:  MAGMA       Date:  2011-06-28       Impact factor: 2.310

5.  The core network in absence epilepsy. Differences in cortical and thalamic BOLD response.

Authors:  P W Carney; R A J Masterton; A S Harvey; I E Scheffer; S F Berkovic; G D Jackson
Journal:  Neurology       Date:  2010-08-11       Impact factor: 9.910

Review 6.  Adult care in phenylketonuria and hyperphenylalaninaemia: the relevance of neurological abnormalities.

Authors:  D P Brenton; J Pietz
Journal:  Eur J Pediatr       Date:  2000-10       Impact factor: 3.183

7.  Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels.

Authors:  Anatoly E Martynyuk; Deniz A Ucar; Dawn D Yang; Wendy M Norman; Paul R Carney; Donn M Dennis; Philip J Laipis
Journal:  Epilepsia       Date:  2007-05-01       Impact factor: 5.864

8.  Hemodynamic changes preceding the interictal EEG spike in patients with focal epilepsy investigated using simultaneous EEG-fMRI.

Authors:  Julia Jacobs; Pierre Levan; Friederike Moeller; Rainer Boor; Ulrich Stephani; Jean Gotman; Michael Siniatchkin
Journal:  Neuroimage       Date:  2009-01-23       Impact factor: 6.556

9.  EEG in phenylketonuria. Attempt to establish clinical importance of EEG changes.

Authors:  P T Gross; S Berlow; V E Schuett; R G Fariello
Journal:  Arch Neurol       Date:  1981-02

10.  Neurological deterioration in young adults with phenylketonuria.

Authors:  A J Thompson; I Smith; D Brenton; B D Youl; G Rylance; D C Davidson; B Kendall; A J Lees
Journal:  Lancet       Date:  1990-09-08       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.